{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:02:33Z","timestamp":1740135753048,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T00:00:00Z","timestamp":1604275200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T00:00:00Z","timestamp":1604275200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Ministry of Education, Culture, Sports, Science and Technology of Japan through grant\u2010in\u2010aid","award":["17K09488"],"award-info":[{"award-number":["17K09488"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s00380-020-01715-9","type":"journal-article","created":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T20:02:31Z","timestamp":1604347351000},"page":"499-508","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association between infectious event and de novo malignancy after heart transplantation"],"prefix":"10.1007","volume":"36","author":[{"given":"Chie","family":"Bujo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2810-8040","authenticated-orcid":false,"given":"Eisuke","family":"Amiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Hatano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisataka","family":"Maki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Narita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyoko","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Ando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shogo","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issei","family":"Komuro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,2]]},"reference":[{"key":"1715_CR1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jjcc.2018.11.011","volume":"73","author":"Y Kimura","year":"2019","unstructured":"Kimura Y, Yanase M, Mochizuki H, Iwasaki K, Toda K, Matsuda S, Takenaka H, Kumai Y, Kuroda K, Nakajima S, Watanabe T, Ikura MM, Wada K, Matsumoto Y, Seguchi O, Fukushima S, Fujita T, Kobayashi J, Fukushima N (2019) De novo malignancy in heart transplant recipients: a single center experience in Japan. J Cardiol 73:255\u2013261","journal-title":"J Cardiol"},{"key":"1715_CR2","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1253\/circj.CJ-16-0976","volume":"81","author":"N Fukushima","year":"2017","unstructured":"Fukushima N, Ono M, Saiki Y, Sawa Y, Nunoda S, Isobe M (2017) Registry report on heart transplantation in Japan. Circ J 81:298\u2013303","journal-title":"Circ J"},{"key":"1715_CR3","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1148\/rg.2016150175","volume":"36","author":"VS Katabathina","year":"2016","unstructured":"Katabathina VS, Menias CO, Tammisetti VS, Lubner MG, Kielar A, Shaaban A, Mansour J, Surabhi VR, Hara AK (2016) Malignancy after solid organ transplantation: comprehensive imaging review. Radiographics 36:1390\u20131407","journal-title":"Radiographics"},{"key":"1715_CR4","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1097\/TP.0b013e318270bc7b","volume":"94","author":"MS Sampaio","year":"2012","unstructured":"Sampaio MS, Cho YW, Qazi Y, Bunnapradist S, Hutchinson IV, Shah T (2012) Posttransplant malignancies in solid organ adult recipients: an analysis of the U.S National Transplant Database. Transplantation 94:990\u2013998","journal-title":"Transplantation"},{"key":"1715_CR5","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1002\/ijc.27765","volume":"132","author":"B Krynitz","year":"2013","unstructured":"Krynitz B, Edgren G, Lindel\u00f6f B, Baecklund E, Brattstr\u00f6m C, Wilczek H, Smedby KE (2013) Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970\u20132008\u2014a Swedish population-based study. Int J Cancer 132:1429\u20131438","journal-title":"Int J Cancer"},{"key":"1715_CR6","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.1016\/j.jacc.2019.03.499","volume":"73","author":"R Asleh","year":"2019","unstructured":"Asleh R, Clavell AL, Pereira NL, Smith B, Briasoulis A, Alnsasra H, Kremers WK, Habermann TM, Otley CC, Li X, Edwards BS, Stulak JM, Daly RC, Kushwaha SS (2019) Incidence of malignancies in patients treated with sirolimus following heart transplantation. J Am Coll Cardiol 73:2676\u20132688","journal-title":"J Am Coll Cardiol"},{"key":"1715_CR7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","volume":"36","author":"TC Horan","year":"2008","unstructured":"Horan TC, Andrus M, Dudeck MA (2008) CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 36:309\u2013332","journal-title":"Am J Infect Control"},{"key":"1715_CR8","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/j.healun.2005.03.019","volume":"24","author":"S Stewart","year":"2005","unstructured":"Stewart S, Winters GL, Fishbein MC, Tazelaar HD, Kobashigawa J, Abrams J, Andersen CB, Angelini A, Berry GJ, Burke MM, Demetris AJ, Hammond E, Itescu S, Marboe CC, McManus B, Reed EF, Reinsmoen NL, Rodriguez ER, Rose AG, Rose M, Suciu-Focia N, Zeevi A, Billingham ME (2005) Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 24:1710\u20131720","journal-title":"J Heart Lung Transplant"},{"key":"1715_CR9","doi-asserted-by":"publisher","first-page":"3694","DOI":"10.1016\/j.transproceed.2010.07.107","volume":"42","author":"AO Doesch","year":"2010","unstructured":"Doesch AO, M\u00fcller S, Konstandin M, Celik S, Kristen A, Frankenstein L, Ehlermann P, Sack FU, Katus HA, Dengler TJ (2010) Malignancies after heart transplantation: incidence, risk factors, and effects of calcineurin inhibitor withdrawal. Transplant Proc 42:3694\u20133699","journal-title":"Transplant Proc"},{"key":"1715_CR10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jacc.2017.10.077","volume":"71","author":"JC Youn","year":"2018","unstructured":"Youn JC, Stehlik J, Wilk AR, Cherikh W, Kim IC, Park GH, Lund LH, Eisen HJ, Kim DY, Lee SK, Choi SW, Han S, Ryu KH, Kang SM, Kobashigawa JA (2018) Temporal trends of de novo malignancy development after heart transplantation. J Am Coll Cardiol 71:40\u201349","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"1715_CR11","doi-asserted-by":"publisher","first-page":"e12998","DOI":"10.1111\/ctr.12998","volume":"31","author":"C S\u00f6derlund","year":"2017","unstructured":"S\u00f6derlund C, R\u00e5degran G (2017) Acute cellular rejection later than one year after heart transplantation: a single-center retrospective study at University Hospital in Lund 1988\u20132010. Clin Transplant 31(7):e12998","journal-title":"Clin Transplant"},{"issue":"3","key":"1715_CR12","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/lt.25411","volume":"25","author":"CC Jadlowiec","year":"2019","unstructured":"Jadlowiec CC, Morgan PE, Nehra AK, Hathcock MA, Kremers WK, Heimbach JK, Wiesner RH, Taner T (2019) Not all cellular rejections are the same: differences in early and late hepatic allograft rejection. Liver Transpl 25(3):425\u2013435","journal-title":"Liver Transpl"},{"issue":"1","key":"1715_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/TP.0000000000001447","volume":"101","author":"JW de Fijter","year":"2017","unstructured":"de Fijter JW (2017) Cancer and mTOR inhibtors in transplant recipients. Transplantation 101(1):45\u201355","journal-title":"Transplantation"},{"key":"1715_CR14","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1161\/CIRCULATIONAHA.111.081059","volume":"126","author":"GM Fr\u00f6hlich","year":"2012","unstructured":"Fr\u00f6hlich GM, Rufibach K, Enseleit F, Wolfrum M, von Babo M, Frank M, Berli R, Hermann M, Holzmeister J, Wilhelm M, Falk V, Noll G, L\u00fcscher TF, Ruschitzka F (2012) Statins and the risk of cancer after heart transplantation. Circulation 126:440\u2013447","journal-title":"Circulation"},{"key":"1715_CR15","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1111\/j.1600-6143.2008.02196.x","volume":"8","author":"MG Crespo-Leiro","year":"2008","unstructured":"Crespo-Leiro MG, Alonso-Pulp\u00f3n L, V\u00e1zquez de Prada JA, Almenar L, Ariz\u00f3n JM, Brossa V, Delgado JF, Fernandez-Ya\u00f1ez J, Manito N, R\u00e1bago G, Lage E, Roig E, Diaz-Molina B, Pascual D, Mu\u00f1iz J (2008) Malignancy after heart transplantation: incidence, prognosis and risk factors. Am J Transplant 8:1031\u20131039","journal-title":"Am J Transplant"},{"key":"1715_CR16","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1016\/j.transproceed.2016.03.037","volume":"48","author":"J Van Keer","year":"2016","unstructured":"Van Keer J, Droogn\u00e9 W, Van Cleemput J, V\u00f6r\u00f6s G, Rega F, Meyns B, Janssens S, Vanhaecke J (2016) Cancer after heart transplantation: a 25-year single-center perspective. Transplant Proc 48:2172\u20132177","journal-title":"Transplant Proc"},{"key":"1715_CR17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.sder.2011.02.003","volume":"30","author":"MK Singh","year":"2011","unstructured":"Singh MK, Brewer JD (2011) Current approaches to skin cancer management in organ transplant recipients. Semin Cutan Med Surg 30:35\u201347","journal-title":"Semin Cutan Med Surg"},{"key":"1715_CR18","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.intimp.2019.01.035","volume":"69","author":"N Saber-Moghaddam","year":"2019","unstructured":"Saber-Moghaddam N, Nomani H, Sahebkar A, Johnston TP, Mohammadpour AH (2019) The change of immunosuppressive regimen from calcineurin inhibitors to mammalian target of rapamycin (mTOR) inhibitors and its effect on malignancy following heart transplantation. Int Immunopharmacol 69:150\u2013158","journal-title":"Int Immunopharmacol"},{"key":"1715_CR19","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.2165\/00003495-200767080-00006","volume":"67","author":"A Gutierrez-Dalmau","year":"2007","unstructured":"Gutierrez-Dalmau A, Campistol JM (2007) Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review. Drugs 67:1167\u20131198","journal-title":"Drugs"},{"key":"1715_CR20","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1001\/jamadermatol.2017.0045","volume":"153","author":"CL Chung","year":"2017","unstructured":"Chung CL, Nadhan KS, Shaver CM, Ogrich LM, Abdelmalek M, Cusack CA, Malat GE, Pritchett EN, Doyle A (2017) Comparison of posttransplant dermatologic diseases by race. JAMA Dermatol 153:552\u2013558","journal-title":"JAMA Dermatol"},{"key":"1715_CR21","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1007\/s00595-018-1628-9","volume":"48","author":"T Miyazaki","year":"2018","unstructured":"Miyazaki T, Sato S, Kondo T, Kusaka M, Gotoh M, Saiki Y, Ono M, Kokudo N, Enosawa S, Satoh S, Soeda E, Furukawa H, Kobayashi E, Nagayasu T (2018) National survey of de novo malignancy after solid organ transplantation in Japan. Surg Today 48:618\u2013624","journal-title":"Surg Today"},{"key":"1715_CR22","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.transproceed.2011.02.069","volume":"43","author":"DR Snydman","year":"2011","unstructured":"Snydman DR, Limaye AP, Potena L, Zamora MR (2011) Update and review: state-of-the art management of cytomegalovirus infection and disease following thoracic organ transplantation. Transplant Proc 43:S1\u2013S17","journal-title":"Transplant Proc"},{"key":"1715_CR23","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.transproceed.2010.02.042","volume":"42","author":"JM Kim","year":"2010","unstructured":"Kim JM, Lee SK, Kim SJ, Joh JW, Kwon CH, Choe YH, Shin M, Kim EY, Moon JI, Jung GO, Choi GS (2010) Risk factors for posttransplant lymphoproliferative disorder in pediatric liver transplant recipients with cytomegalovirus antigenemia. Translant Proc 42:895\u2013899","journal-title":"Translant Proc"},{"key":"1715_CR24","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1097\/TP.0b013e31827df7a7","volume":"95","author":"P Jaksch","year":"2013","unstructured":"Jaksch P, Wiedemann D, Kocher A, Murak\u00f6zy G, Augustin V, Klepetko W (2013) Effect of cytomegalovirus immunoglobulin on the incidence of lymphoproliferative disease after lung transplantation: single-center experience with 1157 patients. Transplantation 95:766\u2013772","journal-title":"Transplantation"},{"issue":"suppl 3","key":"1715_CR25","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/TP.0000000000001094","volume":"100","author":"P Grossi","year":"2016","unstructured":"Grossi P, Mohacsi P, Szabolcs Z, Potena L (2016) Cytomegalovirus immunoglobulin after thoracic transplantation: an overview. Transplantation 100(suppl 3):S1\u2013S4","journal-title":"Transplantation"},{"key":"1715_CR26","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1111\/ajt.13863","volume":"16","author":"Z Jiyad","year":"2016","unstructured":"Jiyad Z, Olsen CM, Burke MT, Isbel NM, Green AC (2016) Azathioprine and risk of skin cancer in organ transplant recipients: systematic review and meta-analysis. Am J Transplant 16:3490\u20133503","journal-title":"Am J Transplant"},{"key":"1715_CR27","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1097\/01.TP.0000063934.89714.19","volume":"75","author":"M Majewski","year":"2003","unstructured":"Majewski M, Korecka M, Joergensen J, Fields L, Kossev P, Schuler W, Shaw L, Wasik MA (2003) Immunosuppressive TOR kinase inhibitor everolimus (RAD) suppresses growth of cells derived from posttransplant lymphoproliferative disorder at allograft-protecting doses. Transplantation 75:1710\u20131717","journal-title":"Transplantation"},{"key":"1715_CR28","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1001\/jamaoncol.2015.5137","volume":"2","author":"SA Acuna","year":"2016","unstructured":"Acuna SA, Fernandes KA, Daly C, Hicks LK, Sutradhar R, Kim SJ, Baxter NN (2016) Cancer mortality among recipients of solid-organ transplantation in Ontario, Canada. JAMA Oncol 2:463\u2013469","journal-title":"JAMA Oncol"},{"key":"1715_CR29","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.healun.2010.05.034","volume":"29","author":"MR Costanzo","year":"2010","unstructured":"Costanzo MR, Dipchand A, Starling R, Anderson A, Chan M, Desai S, Fedson S, Fisher P, Gonzales-Stawinski G, Martinelli L, McGiffin D, Smith J, Taylor D, Meiser B, Webber S, Baran D, Caroni M, Dengler T, Feldman D, Frigerio M, Kfoury A, Kim D, Kobashigawa J, Shullo M, Stehlik J, Teuteberg J, Uber P, Zuckermann A, Hunt S, Bruch M, Bhat G, Canter C, Chinnock R, Crespo-Leiro M, Delgado R, Dobbels F, Grady K, Kao W, Lamour J, Parry G, Patel J, Pini D, Towbin J, Wolfel G, Delgado D, Eisen H, Goldberg L, Hosenpud J, Johnson M, Keogh A, Lewis C, O\u2019Connell J, Rogers J, Ross H, Russell S, Vanhaecke J (2010) The International Society of Heart and Lung Transplantation guidelines for the care of heart transplant rexipients. J Heart Lung Transplant 29:914\u2013956","journal-title":"J Heart Lung Transplant"},{"key":"1715_CR30","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1200\/JCO.2008.20.0857","volume":"27","author":"JS Knight","year":"2009","unstructured":"Knight JS, Tsodikov A, Cibrik DM, Ross CW, Kaminski MS, Blayney DW (2009) Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center. J Clin Oncol 27:3354\u20133362","journal-title":"J Clin Oncol"},{"key":"1715_CR31","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1034\/j.1399-3062.2001.003002070.x","volume":"2","author":"SM Cockfield","year":"2001","unstructured":"Cockfield SM (2001) Identifying the patient at risk for post-transplant lymphoproliferative disorder. Transpl Infect Dis 2:70\u201378","journal-title":"Transpl Infect Dis"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-020-01715-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00380-020-01715-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-020-01715-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T03:05:57Z","timestamp":1615259157000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00380-020-01715-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,2]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["1715"],"URL":"https:\/\/doi.org\/10.1007\/s00380-020-01715-9","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"type":"print","value":"0910-8327"},{"type":"electronic","value":"1615-2573"}],"subject":[],"published":{"date-parts":[[2020,11,2]]},"assertion":[{"value":"26 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"EA and MH belong to the Department of Therapeutic Strategy for Heart Failure, Graduate School of Medicine, University of Tokyo, which is endowed by Actelion Pharmaceuticals Japan, Otsuka Pharmaceutical, Nipro Corporation, Terumo Corporation, Senko Medical Instrument, Century Medical, KCI Licensing, Abbott Medical Japan, Mochida Pharmaceutical, Nippon Shinyaku and Teijin Pharma Limited.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}